BSE filing, NSE: UTIAMC. Summary written from the filing by ALFA Finder's alert engine.
UTI Asset Management Company Ltd: key numbers
- Share price
- ₹835.80
- Market cap
- ₹10,743 Cr
- Revenue (annual)
- ₹1,698 Cr
- Net profit (annual)
- ₹404.1 Cr
- P/E (TTM)
- 22.4×Sector 19.5×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UTI Asset Management Company Ltd
All →UTI Asset Management Company Other Announcement
UTI Asset Management Company announced that its Registrar and Share Transfer Agent, KFin Technologies Limited, is shifting its corporate office. The relocation to Kokapet, Telangana is effective from December 1, 2026.
UTI Asset Management Company Earnings Call Transcript: Key Takeaways
UTI AMC reports steady Q2 FY27 growth despite market volatility, focusing on its Mission 2031 strategy for AUM expansion.
UTI Asset Management Company Investor Presentation: Key Takeaways
UTI AMC Q2 FY27: consolidated revenue ₹414cr (-1% YoY), PAT ₹132cr (+17%), Core PAT ₹131cr (+22%). UTI MF QAAUM ₹4.02 lakh cr (+6.3% YoY); group AUM down 27% YoY on EPFO reallocation.
UTI Asset Management Company Q2 FY27 Results: Net Profit ₹132.3 Cr, Up 0.1% YoY
UTI Asset Management Company Ltd reported revenue from operations of ₹414.6 Cr (-1.0% YoY) and net profit of ₹132.3 Cr (+0.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹132.3 Cr · +0.1% YoY
UTI Asset Management Company Other Announcement
This document details the quarterly shareholding pattern for UTI Asset Management Company Ltd, providing a breakdown of share ownership as required by SEBI regulations.
UTI Asset Management Company Annual General Meeting
UTI AMC postal ballot results approved appointment of Narayan Subramaniam Ayypankav as Non-Executive Independent Director. E-voting concluded 7 October 2026 with requisite majority.
Other management change announcements
All →Jivial Industries Management Change
Jivial Industries appointed Shivam Dineshbhai Sakariya as Additional Non-Executive Independent Director effective 5 November 2026. The NRC recommended the appointment.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Texmaco Rail & Engineering Management Change
Texmaco Rail & Engineering has re-appointed Mr. Udyavar Vittal Kamath as an Executive Director (WTD) with effect from 1 February 2027 for a 12-month term. The filing is a Regulation 30 management change disclosure.
- Execution
- 12 months from 1 February 2027
Windlas Biotech Management Change
Windlass Biotech reports Mr. Ashok Kumar Windlass ceased as Executive Director, resigning for succession planning, effective 5 November 2026. He moves to Founder President, and Hitesh Windlass becomes Managing Director.
Panasonic Energy India Company Management Change
Panasonic Energy India's Company Secretary and Compliance Officer, Srishti Jain, has resigned effective 30 November 2026. The board accepted the resignation at its 5 November 2026 meeting.
Varvee Global Management Change
Varvee Global's statutory auditor, Pankaj R Shah & Associates, resigned with immediate effect on 5 November 2026, citing preoccupancy with other audit assignments. The filing is a mandatory Regulation 30 auditor-resignation disclosure with no monetary value.